Carbapenem resistance and susceptibility to Ceftazidima/avibactam and Ceftolozane/tazobactam in Pseudomonas aeruginosa and Enterobacterales in a reference laboratory in Lima, Peru: A cross-sectional study
PLOS One · 24.08.2026 · 21 (8) · e0356004
DOI: 10.1371/journal.pone.0356004 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS One, online erschienen am 24.08.2026. Verfasst von Juan Carlos Gómez de la Torre Pretell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorios Roe, Lima, Lima, Peru. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Cephalosporins, Anti-Bacterial Agents, Azabicyclo Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Company Foundation.
Abstract (Originalsprache)
Carbapenem resistance in Pseudomonas aeruginosa and Enterobacterales is a growing threat, with intrinsic and acquired resistance mechanisms resulting in the need for new therapeutic options. In Peru, data on resistance patterns and the effectiveness of new antibiotic combinations are limited A descriptive, cross-sectional, retrospective study was conducted on P. aeruginosa and Enterobacterales clinical isolates collected from 2019 to 2024 at a reference laboratory in Lima, Peru, originating from various public and private healthcare centers. Bacterial identification was performed using VITEK MS MALDI-TOF, and antimicrobial susceptibility testing via VITEK 2 and/or Kirby-Bauer disk diffusion. Carbapenemase production was detected using colorimetric, immunochromatographic, and molecular methods, including the FilmArray® BCID panel for bloodstream infections. Microbiological and epidemiological variables were analyzed with Poisson regression models. A total of 173,308 isolates were analyzed, with E. coli (74%) and K. pneumoniae (10.6%) being most prevalent. Most samples (92%) were urinary. Meropenem resistance in P. aeruginosa reached 33% overall and 60% in respiratory specimens. K. pneumoniae showed 3.4% carbapenem resistance. Among carbapenem-resistant isolates, 43.7% were carbapenemase producers. Carbapenemase production was highest in carbapenem-resistant K. pneumoniae (93.1%), E. coli (87.3%), and P. mirabilis (77.3%), but only 32.7% in P. aeruginosa . Among carbapenemase-producing Enterobacterales, metallo-β-lactamases predominated, with bla-NDM detected in 69.6% of K. pneumoniae and bla-OXA-48-like in 100% of E. coli . Ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (C/T) were highly active (>89%) against non-carbapenemase-producing P. aeruginosa , but
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratorios Roe, Lima, Lima, Peru.
- Instituto de Investigaciones en Ciencias Biomedicas, Universidad Ricardo Palma, Lima, Lima, Peru.
- Facultad de Ciencias de la Salud, Universidad Privada de Tacna, Tacna, Tacna, Peru.
- MSD Peru, Lima, Lima, Peru.
- RDMA MSD LATAM, São Paulo, São Paulo, Brazil.
ORCID-Profile: Juan Carlos Gómez de la Torre Pretell, Luis Alvarado Ríos
Förderung
- Merck Company Foundation
Zitieren
APA
Gómez de la Torre Pretell, J. C., Hueda-Zavaleta, M., Alvarado Ríos, L., Valenzuela-Rodríguez, G., La Rosa, A. M., & Polis, T. (2026). Carbapenem resistance and susceptibility to Ceftazidima/avibactam and Ceftolozane/tazobactam in Pseudomonas aeruginosa and Enterobacterales in a reference laboratory in Lima, Peru: A cross-sectional study. PLOS One, 21(8), e0356004. https://doi.org/10.1371/journal.pone.0356004
Vancouver
Gómez de la Torre Pretell JC, Hueda-Zavaleta M, Alvarado Ríos L, Valenzuela-Rodríguez G, La Rosa AM, Polis T. Carbapenem resistance and susceptibility to Ceftazidima/avibactam and Ceftolozane/tazobactam in Pseudomonas aeruginosa and Enterobacterales in a reference laboratory in Lima, Peru: A cross-sectional study. PLOS One. 2026;21(8):e0356004. doi:10.1371/journal.pone.0356004
BibTeX
@article{GmezdelaTorrePretell2026,
author = {Gómez de la Torre Pretell, Juan Carlos and Hueda-Zavaleta, Miguel and Alvarado Ríos, Luis and Valenzuela-Rodríguez, German and La Rosa, Alberto Martin and Polis, Thales},
title = {Carbapenem resistance and susceptibility to Ceftazidima/avibactam and Ceftolozane/tazobactam in Pseudomonas aeruginosa and Enterobacterales in a reference laboratory in Lima, Peru: A cross-sectional study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0356004},
doi = {10.1371/journal.pone.0356004}
}
EUVIMED